Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Puma Biotechnology (PBYI) Non Operating Income (2017 - 2025)

Puma Biotechnology's Non Operating Income history spans 9 years, with the latest figure at $143000.0 for Q4 2025.

  • For Q4 2025, Non Operating Income rose 112.69% year-over-year to $143000.0; the TTM value through Dec 2025 reached -$494000.0, up 81.44%, while the annual FY2025 figure was $1.0 million, 114.96% up from the prior year.
  • Non Operating Income reached $143000.0 in Q4 2025 per PBYI's latest filing, up from -$330000.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $8.7 million in Q4 2023 to a low of -$23.4 million in Q4 2022.
  • Average Non Operating Income over 5 years is -$1.2 million, with a median of $63000.0 recorded in 2022.
  • Peak YoY movement for Non Operating Income: tumbled 31774.32% in 2022, then skyrocketed 368.92% in 2024.
  • A 5-year view of Non Operating Income shows it stood at $74000.0 in 2021, then crashed by 31774.32% to -$23.4 million in 2022, then soared by 137.25% to $8.7 million in 2023, then tumbled by 112.91% to -$1.1 million in 2024, then soared by 112.69% to $143000.0 in 2025.
  • Per Business Quant, the three most recent readings for PBYI's Non Operating Income are $143000.0 (Q4 2025), -$330000.0 (Q3 2025), and $410000.0 (Q2 2025).